Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 530.00
Bid: 530.00
Ask: 532.00
Change: 1.00 (0.19%)
Spread: 2.00 (0.377%)
Open: 523.00
High: 530.00
Low: 523.00
Prev. Close: 529.00
POLR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AUM Update

10 Apr 2015 07:00

RNS Number : 7922J
Polar Capital Holdings PLC
10 April 2015
 

10 April 2015

Polar Capital Holdings plc

AUM Update

 

 

Polar Capital Holdings plc ("Polar Capital" or the "Group") the specialist asset manager today provides its regular quarterly update of its unaudited statement of its Assets under Management ("AUM").

 

 

Group AUM (unaudited)

Polar Capital reports that as at 31 March 2015 its AUM were $12.3bn compared to $12.9bn at the end of December 2014 and $13.2bn at the end of March 2014.

 

The table below sets out the movements in Polar Capital's AUM over the twelve month period:

AUM movement

twelve months to 31 March 2015

Long only funds

$m

Alternative funds

$m

Total

$m

As at 31 March 2014

$12,315m

$934m

$13,249m

Net subscriptions / (redemptions)

$(2,228)m

$254m

$(1,974)m

Closure of EMN team

Nil

$(67)m

$(67)m

Market movement and performance

$1,098m

$(50)m

$1,048m

Total AUM at 31 March 2015

$11,185m

$1,071m

$12,256m

 

Comment

Net inflows across the Group's non Japan range of funds of $0.3bn over the past twelve months have been offset by $2.3bn of outflows from our Japan business ($1.6bn over the past six months) following both disappointing performance that has been exacerbated by the team's style bias, as well as uncertainty over the direction of the Japanese equity market. These Japan flows follow the $3.0bn of net inflows that were received in the previous twelve month period.

 

The combination of these Japan outflows with good inflows into a number of our other products over the year has delivered the side effect of making the business more balanced with Japan now accounting for some 30% of the Group's AUM down from its peak of 43%.

 

We continue to believe that over the medium term the Group is well placed to grow assets further given the number of products that have considerable scope for asset growth including the launch of 3 new funds over the past year. This assumes there is no meaningful deterioration in the overall outlook for global equity markets.

 

The confidence in our ability to grow assets in the medium term is a function of the strong performance of our products that can be demonstrated by the good performance numbers of Polar Capital's product range where 11 of our 14 Lipper rated open ended funds (with at least a 1 year track record) are over one year first or second quartile continuing the excellent record since inception.

 

 

1 year

3 Years

5 years

Since

inception

1st quartile

6 funds

5 funds

5 funds

10 funds

2nd quartile

5 funds

3 funds

N/A

3 funds

3rd quartile

1 fund

1 fund

1 fund

1 fund

4th quartile

2 funds

1 fund

N/A

N/A

 

 

For further information please contact:

 

Polar Capital

Tim Woolley (CEO)

John Mansell (COO)

+44 (0)20 7227 2700

Canaccord Genuity - Nomad and Broker

Simon Bridges (QE)

Martin Green

Sunil Duggal

Kit Stephenson

+44 (0)20 7523 8000

 

Camarco

Ed Gascoigne-Pees

 

+44 (0)20 3757 4984

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEASLNESPSEFF
Date   Source Headline
17th Apr 20243:55 pmRNSDirector/PDMR Shareholding
12th Apr 20245:43 pmRNSHolding(s) in Company
11th Apr 20247:00 amRNSAuM Update
9th Apr 20244:01 pmRNSChange of Company Secretary
15th Mar 20243:02 pmRNSForm 8.3 - Renalytix PLC
15th Mar 202410:23 amRNSForm 8.3 - Renalytix PLC - Replacement
13th Mar 20246:14 pmRNSForm 8.3 - RENALYTIX PLC
7th Mar 20244:30 pmRNSHolding(s) in Company
6th Mar 20245:47 pmRNSForm 8.3 - DIRECT LINE INSURANCE GROUP PLC
6th Mar 20245:37 pmRNSForm 8.3 - RENALYTIX PLC
27th Feb 20242:19 pmRNSForm 8.3 - Wincanton PLC
7th Feb 20242:09 pmRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSBlock listing Interim Review
25th Jan 20244:53 pmRNSForm 8.3 -Wincanton PLC
11th Jan 20247:00 amRNSAuM Update
10th Jan 20242:54 pmRNSHolding(s) in Company
10th Jan 20242:51 pmRNSHolding(s) in Company
20th Nov 20237:00 amRNSPolar Capital Holdings Unaudited interim results
9th Nov 20237:00 amRNSInvestor Presentation covering Interim Results
26th Oct 20237:00 amRNSNotice of Interim Results
12th Oct 20237:00 amRNSAuM Update
28th Sep 20235:36 pmRNSResult of AGM
18th Aug 20234:45 pmRNSDirector/PDMR Shareholding
1st Aug 202312:05 pmRNSBlock listing Interim Review
19th Jul 20234:34 pmRNSDirector/PDMR Shareholding
18th Jul 20234:30 pmRNSDirector/PDMR Shareholding
13th Jul 202311:01 amRNSDirector/PDMR Shareholding - Replacement
13th Jul 202310:48 amRNSDirector/PDMR Shareholding
13th Jul 202310:31 amRNSDirector/PDMR Shareholding
13th Jul 20237:00 amRNSAuM Update
26th Jun 20233:34 pmRNSInvestor Presentation covering Full Year Results
26th Jun 20237:00 amRNSGroup Audited Results for year ended 31 March 2023
1st Jun 20237:00 amRNSTotal Voting Rights
25th May 202312:26 pmRNSIssue of Equity
10th May 20233:10 pmRNSDirector/PDMR Shareholding
21st Apr 20232:36 pmRNSHolding(s) in Company
14th Apr 20234:01 pmRNSDirector/PDMR Shareholding
13th Apr 20237:00 amRNSAuM Update
31st Mar 202312:23 pmRNSDirector/PDMR Shareholding
10th Mar 20233:17 pmRNSDirector/PDMR Shareholding
24th Feb 20235:18 pmRNSForm 8.3 - REDX Pharma PLC
16th Feb 20235:06 pmRNSDirector/PDMR Shareholding
7th Feb 202311:09 amRNSHolding(s) in Company
1st Feb 20237:00 amRNSBlock listing Interim Review
12th Jan 20237:00 amRNSAuM Update
30th Dec 20227:00 amRNSDirectorate Change
21st Nov 20227:00 amRNSUnaudited interim results
15th Nov 20227:00 amRNSInvestor Presentation covering Interim Results
24th Oct 20227:00 amRNSNotice of Results
19th Oct 20222:52 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.